These findings indicate that time-dependent loss of miR-548c-3p contributes to E2F3 and FOXM1 activation through a post-transcriptional regulatory mechanism, highlighting this miRNA-oncogene axis as a potential prognostic signature and therapeutic target in breast cancer. This evidence concerns the gene E2F3 and breast cancer.